Clinical Trials Logo

Filter by:
NCT ID: NCT04668365 Recruiting - Clinical trials for Diffuse Large B Cell Lymphoma

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Start date: December 25, 2020
Phase: Phase 2
Study type: Interventional

This is a prospective single arm, multi-center, phase II clinical trial to observe the efficacy and safety of zanubrutinib combined with standard chemotherapy in the treatment for patients with diffuse large B cell lymphoma and CD79A/CD79B genetic abnormality.

NCT ID: NCT04668118 Recruiting - Dry Eye Syndromes Clinical Trials

The Effect of 3% Diquafosol Ophthalmic Solution on Visual Display Terminal-associated Dry Eye

Start date: February 1, 2021
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the efficacy and safety of 3% Diquafosol Ophthalmic Solution for visual display terminal (VDT)-associated dry eye and to investigate the mechanism of treatment.

NCT ID: NCT04668027 Recruiting - Clinical trials for Chronic Airway Disease

Impulse Oscillation to Evaluate Diagnostic Efficacy in Patients With Chronic Airway Disease

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of the research is to explore the diagnostic efficacy of impulse oscillation (IOS) before and after bronchial provocation test (BPT) and bronchial dilation test (BDT) in chronic airway disease.

NCT ID: NCT04667819 Recruiting - Dry Eye Clinical Trials

Wireless Micropump in Dry Eye Patients

Start date: December 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to carry out a trial to get more convincing and valuable results of the wireless micropump in dry eye patients and compare the outcomes before and after eye drops usage. The investigators hope to investigate the micropump comprehensively, including the comparison of tear film break-up time, corneal epithelium defect percentage, and tear film thickness. To meet the demands of a trial, all the examination equipment should be the same for each patient, and this will limit the variations within a study.

NCT ID: NCT04667793 Recruiting - Clinical trials for Thymic Epithelial Tumor

Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor

Start date: January 31, 2021
Phase: Phase 2
Study type: Interventional

This is a phase II, single-arm, open-label study to evaluate the efficacy and safety of neoadjuvant Toripalimab + chemotherapy followed by radical surgery as first-line treatment in patients with locally advanced thymic epithelial tumor.

NCT ID: NCT04667429 Recruiting - Insomnia Clinical Trials

the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets

Start date: January 18, 2021
Phase: Phase 1
Study type: Interventional

Multiple Dose Safety, Tolerability, PK ,PD and Food Effect Study of HEC83518 in Healthy Subjects

NCT ID: NCT04667351 Recruiting - Clinical trials for HepatoCellular Carcinoma

HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial

Start date: March 1, 2019
Phase: Phase 3
Study type: Interventional

Hepatic artery infusion of oxaliplatin, leucovorin and 2400 mg/m² fluorouracil is effective in hepatocellular carcinoma. However, SILIUS study showed that sorafenib plus hepatic artery infusion of cisplatin and fluorouracil did not significantly improve overall survival compared with sorafenib alone. Whether fluorouracil is effevtive is known.

NCT ID: NCT04667299 Recruiting - Clinical trials for Helicobacter Pylori Infection

Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment

Start date: December 20, 2020
Phase: Phase 4
Study type: Interventional

This randomized controlled clinical trial will compare the eradication efficacy of bismuth-metronidazole triple therapy (PPI+bismuth+ metronidazole) with that of bismuth-metronidazole quadruple therapy (PPI+bismuth+ metronidazole+ amoxicillin) for Helicobacter pylori first-line treatment. The completion of this trial will expand new therapy for the treatment of Helicobacter pylori, which can not only ensure clinical efficacy, but also reduce the use of antibiotics.

NCT ID: NCT04667026 Recruiting - HIV Infections Clinical Trials

Observational Study on Patients With HIV/AIDS(OSPWH)

OSPWH
Start date: January 1, 2009
Phase:
Study type: Observational

To establish a follow-up cohort of antiretroviral therapy(ART) for patients with HIV/AIDS, to observe the ART efficacy and adverse reactions, complications in the process of ART, as well as mortality and causes of death, so as to provide basis for further improving ART efficacy and quality of life of the patients.

NCT ID: NCT04666272 Recruiting - Melanoma Clinical Trials

Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

Start date: December 31, 2020
Phase:
Study type: Observational

This is a prospective, open label, single-arm, multicenter, non-interventional study of dabrafenib in combination with trametinib as adjuvant treatment for Chinese patients with stage III BRAF V600 mutation positive melanoma after complete resection.